Home/Filings/4/0000899243-20-035270
4//SEC Filing

Mohsen Paulash 4

Accession 0000899243-20-035270

CIK 0001445283other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 7:10 PM ET

Size

10.9 KB

Accession

0000899243-20-035270

Insider Transaction Report

Form 4
Period: 2020-12-22
Mohsen Paulash
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-12-22+42,16842,168 total
    Exercise: $8.16Exp: 2028-12-03Common Stock (42,168 underlying)
  • Award

    Common Stock

    2020-12-22+36,42836,428 total
  • Award

    Stock Option (Right to Buy)

    2020-12-22+10,54210,542 total
    Exercise: $8.16Exp: 2030-02-17Common Stock (10,542 underlying)
Footnotes (6)
  • [F1]On August 22, 2020, the Issuer (formerly known as Proteostasis Therapeutics, Inc.) entered into an Agreement and Plan of Merger and Reorganization, as amended on November 6, 2020, with Pangolin Merger Sub, Inc. ("Merger Sub"), Yumanity, Inc. (formerly known as Yumanity Therapeutics, Inc.) and Yumanity Holdings, LLC ("Holdings"). On December 22, 2020, Merger Sub was merged with and into Yumanity, Inc., with Yumanity, Inc. surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). Immediately prior to the consummation of the Merger, Holdings was merged with and into Yumanity, Inc., with Yumanity, Inc. as the surviving entity.
  • [F2]The shares were received in exchange for 172,776.09 shares of Yumanity, Inc. common stock in connection with the Merger.
  • [F3]25% of the shares subject to the option vested on December 4, 2019. The remaining 75% vest in equal monthly installments over the subsequent three years.
  • [F4]Received in the Merger in exchange for a stock option to acquire 200,000 shares of Yumanity, Inc. common stock for $1.72 per share.
  • [F5]25% of the shares subject to the option vest on February 18, 2021. The remaining 75% vest in equal monthly installments over the subsequent three years.
  • [F6]Received in the Merger in exchange for a stock option to acquire 50,000 shares of Yumanity, Inc. common stock for $1.72 per share.

Issuer

YUMANITY THERAPEUTICS, INC.

CIK 0001445283

Entity typeother

Related Parties

1
  • filerCIK 0001834063

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 7:10 PM ET
Size
10.9 KB